Welcome to our dedicated page for Church & Dwight Co SEC filings (Ticker: CHD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Church & Dwight Co., Inc. (NYSE: CHD) brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, including current reports on Form 8‑K and other key documents. Church & Dwight describes itself in these filings as a Delaware corporation with principal offices in Ewing, New Jersey, operating as a manufacturer and marketer of personal care, household and specialty products and as the leading U.S. producer of sodium bicarbonate.
Investors researching CHD can use this page to access Form 8‑K filings that report material events, such as quarterly earnings announcements, strategic portfolio actions, and governance changes. Recent 8‑Ks reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, a definitive agreement to sell the VitaFusion and L’il Critters vitamin brands (including related trademarks, licenses and facilities) to Piping Rock Health Products, Inc., and an amendment to the company’s Corporate Governance Guidelines removing limits on board tenure while maintaining an age‑based retirement requirement.
Alongside 8‑Ks, users can locate annual reports on Form 10‑K, quarterly reports on Form 10‑Q, and other filings that provide detail on Church & Dwight’s brand portfolio, segment reporting for its consumer domestic, consumer international and specialty products businesses, and risk factors and accounting policies described by the company. These documents also reflect information about capital structure, dividend practices and board‑level decisions disclosed to regulators.
Stock Titan enhances access to these filings with AI‑powered summaries that highlight the main points of lengthy reports, helping readers quickly understand earnings discussions, portfolio transactions, governance updates and other topics covered in CHD’s SEC submissions. Real‑time updates from EDGAR, combined with simplified explanations of 10‑K and 10‑Q content and visibility into insider‑related filings such as Form 4, allow users to review Church & Dwight’s regulatory record in a structured, accessible format.
Form 4 filing for Church & Dwight Co., Inc. (CHD) details a single insider transaction by director Michael R. Smith on 30 June 2025. Smith acquired 1,248.569 phantom stock units under the company’s Deferred Compensation Plan at a reference price of $96.11 per unit. Phantom stock converts to common shares on a 1-for-1 basis but is ultimately settled in cash according to plan rules. Following this acquisition, Smith’s total phantom stock balance rose to 1,790.974 units, all held directly.
The filing contains no disposals, option exercises, or sales; it is strictly an increase in deferred, cash-settled equity exposure. Because phantom shares mirror common stock performance, the transaction represents an incremental alignment of the director’s economic interests with those of shareholders, albeit with limited absolute dollar value relative to CHD’s market capitalization.
There is no indication of 10b5-1 plan usage and the transaction was not coded as routine compensation. From an investment-sentiment standpoint, insider purchases—especially by outside directors—are generally interpreted as mildly positive signals, though the ~1.25k-share size is not materially significant to corporate fundamentals.
Church & Dwight Co., Inc. (CHD) – Form 4 insider filing
Director Brad Cashaw reported one transaction dated 06/30/2025 involving the company’s phantom stock granted through the Church & Dwight Deferred Compensation Plan.
- Type of security: Phantom stock (cash-settled, converts 1-for-1 to common stock for valuation purposes)
- Amount acquired: 1,248.57 phantom shares
- Transaction code: A (grant under compensation plan)
- Implied price: $96.11 per phantom share
- Post-transaction balance: 4,982.935 phantom shares held directly
No open-market purchase or sale of common shares is disclosed; the grant represents deferred compensation rather than an equity purchase. No additional derivative or non-derivative transactions were reported.
The filing neither amends prior reports nor indicates cessation of insider reporting obligations.
Form 4 indicates that EVP & Chief Technology and Global New Product Officer Carlos G. Linares acquired 26.672 phantom stock units of Church & Dwight Co., Inc. (CHD) on 30 June 2025 at a reference price of $96.11. The phantom shares convert to common stock on a 1-for-1 basis but will be settled in cash according to the company’s Deferred Compensation Plan. Following the transaction, Linares’ aggregate phantom-stock position stands at 17,030.913 units. No common shares were bought or sold, and there is no indication of open-market activity. The filing represents a routine deferred-compensation allocation rather than a market transaction and is unlikely to have a material impact on CHD’s float or insider-ownership profile.
Charles R. Raup, President of US Domestic operations at Church & Dwight, reported significant equity compensation awards on June 25, 2025. The transaction includes:
- 9,000 Restricted Stock Units (RSUs) granted at $95.25 per share, vesting in three equal annual installments starting June 25, 2026
- 31,040 Stock Options with an exercise price of $95.25, exercisable between June 25, 2028 and June 25, 2035
This compensation package demonstrates Church & Dwight's long-term incentive strategy for key executives, with a mix of RSUs and options structured to promote retention and align management interests with shareholders. The RSUs provide immediate value upon vesting, while the options offer potential upside tied to stock price appreciation over a 10-year period.